GPT Healthcare Board Meeting on Nov 5 to Consider Unaudited Results, Dividend

GPT Healthcare Ltd has announced that its Board of Directors will convene on November 5, 2026. The primary agenda items include the consideration and approval of the Unaudited Financial Results for the second quarter and half-year ended September 30, 2026, along with the Statutory Auditors' Limited Review Report. Additionally, the Board will discuss and potentially approve the declaration of an interim dividend for the Financial Year 2026-27. The trading window for company securities will remain closed until November 7, 2026, in line with the company's insider trading code.